Medical Therapy for Cushing's Syndrome in the Twenty-first Century
- PMID: 29754642
- DOI: 10.1016/j.ecl.2018.01.006
Medical Therapy for Cushing's Syndrome in the Twenty-first Century
Abstract
Medical therapy has a useful adjunctive role in many patients with Cushing's syndrome. Patients with pituitary corticotroph adenomas who have received radiation therapy to the sella require medical therapy until the effects of radiation therapy occur. In addition, patients with Cushing's syndrome who cannot undergo surgery promptly, including those who are acutely ill and cannot safely undergo tumor resection, may benefit from medical therapy as a bridge to surgery. Other possible candidates for medical therapy are those with unresectable tumors or those whose tumor location remains unknown despite adequate diagnostic evaluation.
Keywords: Cabergoline; Cushing’s disease; Cushing’s syndrome; Etomidate; Ketoconazole; Metyrapone; Mitotane; Pasireotide.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.Neuroendocrinology. 2010;92 Suppl 1:111-5. doi: 10.1159/000314292. Epub 2010 Sep 10. Neuroendocrinology. 2010. PMID: 20829630 Review.
-
Drugs in the medical treatment of Cushing's syndrome.Expert Opin Emerg Drugs. 2009 Dec;14(4):661-71. doi: 10.1517/14728210903413522. Expert Opin Emerg Drugs. 2009. PMID: 19939210 Review.
-
Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.J Clin Endocrinol Metab. 2011 Sep;96(9):2796-804. doi: 10.1210/jc.2011-0536. Epub 2011 Jul 13. J Clin Endocrinol Metab. 2011. PMID: 21752886
-
Advances in medical therapies for Cushing's syndrome.Discov Med. 2012 Feb;13(69):171-9. Discov Med. 2012. PMID: 22369976 Review.
-
Medical therapy of Cushing's disease.Pituitary. 2002;5(2):77-82. doi: 10.1023/a:1022308429992. Pituitary. 2002. PMID: 12675504 Review.
Cited by
-
Long-term efficacy and safety of once-monthly pasireotide in Cushing's disease: A Phase III extension study.Clin Endocrinol (Oxf). 2019 Dec;91(6):776-785. doi: 10.1111/cen.14081. Epub 2019 Oct 1. Clin Endocrinol (Oxf). 2019. PMID: 31465533 Free PMC article. Clinical Trial.
-
Efficacy and safety of pasireotide for Cushing's disease: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2020 Dec 18;99(51):e23824. doi: 10.1097/MD.0000000000023824. Medicine (Baltimore). 2020. PMID: 33371162 Free PMC article.
-
Cortisol and the Dexamethasone Suppression Test as a Biomarker for Melancholic Depression: A Narrative Review.J Pers Med. 2023 May 16;13(5):837. doi: 10.3390/jpm13050837. J Pers Med. 2023. PMID: 37241007 Free PMC article. Review.
-
Using Etomidate in a Two-month-old Infant with Cushing Syndrome due to Adrenocortical Carcinoma.J Clin Res Pediatr Endocrinol. 2022 Mar 3;14(1):102-106. doi: 10.4274/jcrpe.galenos.2020.2020.0164. Epub 2020 Nov 30. J Clin Res Pediatr Endocrinol. 2022. PMID: 33251784 Free PMC article.
-
Somatostatin receptors in normal and acromegalic somatotroph cells: the U-turn of the clinician to immunohistochemistry report - a review.Rom J Morphol Embryol. 2020 Apr-Jun;61(2):353-359. doi: 10.47162/RJME.61.2.05. Rom J Morphol Embryol. 2020. PMID: 33544787 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical